Neosine (Inosine Pranobex)

Inosine Pranobex works by stimulating key components of the immune system, including the production of cytokines like interferon‑γ and interleukin‑2, and by activating natural killer cells and macrophages. This enhanced immune activity improves the body’s ability to identify and suppress viral replication, providing broad‑spectrum antiviral effects.

The dosage of Neosine is individualized and determined by the prescribing clinician based on the specific infection, patient age, weight, renal and hepatic function, and other clinical factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for Inosine Pranobex during pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To order Neosine, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Unlike direct‑acting antivirals that target specific viral enzymes, Neosine acts as an immunostimulant, enhancing the host’s immune response rather than inhibiting viral replication directly. This mechanism can be advantageous in infections where the immune system needs support, but it may be less specific than agents such as acyclovir for herpes or oseltamivir for influenza.

Neosine should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures or humidity, which could affect its stability.

Neosine is administered orally, typically as tablets or capsules, and should be taken with water as directed by the prescriber. The exact dosing schedule, including frequency and duration of therapy, is determined by the treating physician based on the individual’s clinical condition.

Serious adverse reactions, although rare, can include severe allergic responses such as anaphylaxis, liver dysfunction manifested by elevated enzymes or jaundice, and hematologic abnormalities like leukopenia, thrombocytopenia, or anemia. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, rash, yellowing of the skin or eyes, or unexplained bruising.

Neosine is contraindicated in individuals with a known hypersensitivity to Inosine Pranobex or any of its excipients. Caution is also advised for patients with severe hepatic or renal impairment, and it should be avoided in those receiving live vaccines or potent immunosuppressive therapy unless specifically directed by a physician.